- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells ; volume:15 ; number:1 ; day:16 ; month:3 ; year:2017 ; pages:1-8 ; date:12.2017
Journal of translational medicine ; 15, Heft 1 (16.3.2017), 1-8, 12.2017
- Keyword
-
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie
- Creator
-
Stroncek, David F.
- Contributor
-
Lee, Daniel W.
Ren, Jiaqiang
Sabatino, Marianna
Highfill, Steven
Khuu, Hanh
Shah, Nirali N.
Kaplan, Rosandra N.
Fry, Terry J.
Mackall, Crystal L.
SpringerLink (Online service)
- DOI
-
10.1186/s12967-017-1160-5
- URN
-
urn:nbn:de:1111-201704057840
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stroncek, David F.
- Lee, Daniel W.
- Ren, Jiaqiang
- Sabatino, Marianna
- Highfill, Steven
- Khuu, Hanh
- Shah, Nirali N.
- Kaplan, Rosandra N.
- Fry, Terry J.
- Mackall, Crystal L.
- SpringerLink (Online service)
Other Objects (12)
Chimeric Antigen Receptor T-Cell Therapy
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Targeting cardiac fibrosis with chimeric antigen receptor macrophages
Effectors of the Future: Universal Chimeric Antigen Receptor
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Engineering chimeric antigen receptor-T cells for cancer treatment
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cells for acute myeloid leukemia
Chimeric Antigen Receptor T-Cell Therapy
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Targeting cardiac fibrosis with chimeric antigen receptor macrophages
Effectors of the Future: Universal Chimeric Antigen Receptor
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Engineering chimeric antigen receptor-T cells for cancer treatment
Chimeric antigen receptor T cell therapies for multiple myeloma
Chimeric antigen receptor T cells for acute myeloid leukemia
Chimeric Antigen Receptor T-Cell Therapy
Chimeric antigen receptor–based therapies beyond cancer
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Optimization of chimeric antigen receptor (CAR) therapy
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Targeting cardiac fibrosis with chimeric antigen receptor macrophages
Effectors of the Future: Universal Chimeric Antigen Receptor
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Engineering chimeric antigen receptor-T cells for cancer treatment
Chimeric antigen receptor T cell therapies for multiple myeloma